“The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition”. 2025. SKIN The Journal of Cutaneous Medicine 9 (5): 2669-73. https://doi.org/10.25251/kj8rwg98.